切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2020, Vol. 17 ›› Issue (06) : 577 -582. doi: 10.3877/cma.j.issn.1672-6448.2020.06.017

所属专题: 文献

综述

妊娠期甲状腺癌的超声诊断与治疗进展
黄钰清1, 姚尧2, 吕发勤1,()   
  1. 1. 100853 北京,解放军医学院;572013 三亚,中国人民解放军总医院海南医院超声科
    2. 100871 北京大学国家发展研究院健康老龄与发展研究中心
  • 收稿日期:2019-09-24 出版日期:2020-06-01
  • 通信作者: 吕发勤
  • 基金资助:
    科技部重点研发计划(2016YFC0105006); 国家自然科学基金(81371561,81903392); 中国博士后科学基金(2019M650359)

Advances in ultrasound diagnosis and treatment of thyroid carcinoma in pregnancy

Yuqing Huang1, Yao Yao2, Faqin Lyu1()   

  • Received:2019-09-24 Published:2020-06-01
  • Corresponding author: Faqin Lyu
引用本文:

黄钰清, 姚尧, 吕发勤. 妊娠期甲状腺癌的超声诊断与治疗进展[J]. 中华医学超声杂志(电子版), 2020, 17(06): 577-582.

Yuqing Huang, Yao Yao, Faqin Lyu. Advances in ultrasound diagnosis and treatment of thyroid carcinoma in pregnancy[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2020, 17(06): 577-582.

图1 甲状腺结节二维超声及弹性成像图像。图a为甲状腺良性结节的二维超声及弹性成像图,以绿色为主,质软;图b为甲状腺乳头状癌的二维超声及弹性成像图,以蓝色为主,质硬
图2 甲状腺囊性结节二维超声及超声造影图像。图a为常规二维超声示甲状腺峡部上方囊性结节,边界清楚,内透声差(箭头所示);图b为超声造影示甲状腺囊性结节未见造影剂灌注,呈无增强(箭头所示)
图3 甲状腺乳头状癌二维超声及超声造影图像。图a为常规二维超声示甲状腺低回声结节,边界不清(箭头所示);图b为超声造影显示甲状腺结节呈不均匀低增强(箭头所示)
1
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J]. Thyroid, 2016, 26(1): 1-133.
2
Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017 [J]. CA Cancer J Clin, 2017, 67(1): 7-30.
3
Varghese SS, Varghese A, Ayshford C. Differentiated thyroid cancer and pregnancy [J]. Indian J Surg, 2014, 76(4): 293-296.
4
Nazarpour S, Ramezani TF, Simbar M, et al. Thyroid dysfunction and pregnancy outcomes [J]. Iran J Reprod Med, 2015, 13(7): 387-396.
5
Consortium on Thyroid and Pregnancy-Study Group on Preterm Birth, Korevaar TIM, Derakhshan A, et al. Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Meta-analysis [J]. JAMA, 2019, 322(7): 632-641.
6
Weiss VL, Andreotti RF, Ely KA. Use of the thyroid imaging, reporting, and data system (TI-RADS) scoring system for the evaluation of subcentimeter thyroid nodules [J]. Cancer Cytopathology, 2018, 126(8): 518-524.
7
Stoian D, Timar B, Derban M, et al. Thyroid Imaging Reporting and Data System (TI-RADS): the impact of Quantitative Strain Elastography for better stratification of cancer risks [J]. Med Ultrason, 2015, 17(3): 327-332.
8
张隽,陈文卫. 甲状腺癌超声诊断的研究进展 [J]. 临床超声医学杂志, 2017, 19(11): 766-769.
9
Horvath E, Majlis S, Rossi R, et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management [J]. Clin Endoerinol Metab, 2009, 94(5): 1748-1751.
10
Park JY, Lee HJ, Jang HW, et al. A proposal for at thyroid imaging reporting and data system for ultrasound features of thyroid carcinoma [J]. Thyroid, 2009, 19(11): 1258-1264.
11
Kwak JY, Han KH, Yoon JH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk [J]. Radiology, 2011, 260(3): 892-899.
12
聂芳,汪延芳,耿祥亮, 等. 不同标准TI-RADS分级对甲状腺癌的价值探讨 [J]. 中国超声医学杂志, 2016, 32(11): 967-970.
13
Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum [J]. Thyroid, 2011, 21(10): 1081-1125.
14
Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features [J]. J Clin Endocrinol Metab, 2002, 87(5): 1941-1946.
15
Yang GCH, Fried KO. Most Thyroid Cancers Detected by Sonography Lack Intranodular Vascularity on Color Doppler Imaging: Review of the Literature and Sonographic-Pathologic Correlations for 698 Thyroid Neoplasms [J]. Ultrasound Med, 2017, 36(1): 89-94.
16
Moon HJ, Kwak JY, Kim MJ, et al. Can vascularity at power Doppler US help predict thyroid malignancy? [J]. Radiology, 2010, 255(1): 260-269.
17
Brito JP, Gionfriddo MR, Al Nofal A, et al. The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis [J]. J Clin Endocrinol Metab, 2014, 99(4): 1253-1263.
18
Chua WY, Langer JE, Jones LP. Surveillance Neck Sonography After Thyroidectomy for Papillary Thyroid Carcinoma: Pitfalls in the Diagnosis of Locally Recurrent and Metastatic Disease [J]. J Ultrasound Med, 2017, 36(7): 1511-1530.
19
Giorgadze TA, Baloch ZW, Pasha T, et al. Lymphatic and blood vessel density in the follicular patterned lesions of thyroid [J]. Mod Pathol, 2005, 18(11): 1424-1431.
20
Ophir J, Céspedes I, Ponnekanti H, el at. Elastography: A quantitative method for imaging the elasticity of biological tissues [J]. Ultrason Imaging, 1991, 13(2): 111-134.
21
Yoon JH, Kim EK, Kwak JY, et al. Application of Various Additional Imaging Techniques for Thyroid Ultrasound: Direct Comparison of Combined Various Elastography and Doppler Parameters to Gray-Scale Ultrasound in Differential Diagnosis of Thyroid Nodules [J]. Ultrasound Med Biol, 2018, 44(8): 1679-1686.
22
Shao J, Shen Y, Lyu J, et al. Ultrasound scoring in combination with ultrasound elastography for differentiating benign and malignant thyroid nodules [J]. Clin Endocrinol (Oxf), 2015, 83(2): 254-260.
23
Xue J, Cao XL, Shi L, et al. The diagnostic value of combination of TI-RADS and ultrasound elastography in the differentiation of benign and malignant thyroid nodules [J]. Clin Imaging, 2016, 40(5): 913-916.
24
Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum [J]. Thyroid, 2017, 27(3): 315-389.
25
张波,徐景竹,吴琼. 2015年美国甲状腺学会《成人甲状腺结节与分化型甲状腺癌诊治指南》解读:超声部分 [J]. 中国癌症杂志, 2016, 26(1): 19-24.
26
Haugen BR. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed? [J]. Cancer, 2017, 123(3): 372-381.
27
Zhang Y, Luo YK, Zhang MB, et al. Diagnostic Accuracy of Contrast-Enhanced Ultrasound Enhancement Patterns for Thyroid Nodules [J]. Med Sci Monit, 2016, 22: 4755-4764.
28
Wu Q, Wang Y, Li Y, et al. Diagnostic value of contrast-enhanced ultrasound in solid thyroid nodules with and without enhancement [J]. Endocrine, 2016, 53(2): 480-488.
29
Machado P, Segal S, Lyshchik A, et al. A Novel Microvascular Flow Technique: Initial Results in Thyroids [J]. Ultrasound Q, 2016, 32(1): 67-74.
30
Cantisani V, Bertolotto M, Weskott HP, et al. Growing indications for CEUS: The kidney, testis, lymph nodes, thyroid, prostate, and small bowel [J]. Eur J Radiol, 2015, 84(9): 1675-1684.
31
Sidhu PS, Cantisani V, Dietrich CF, et al. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version) [J] . Ultraschall Med, 2018, 39(2): e2-e44.
32
Hua X, Zhu LP, Li R, et al. Effects of diagnostic contrast-enhanced ultrasound on permeability of placental barrier: a primary study [J]. Placenta, 2009, 30(9): 780-784.
33
Roberts VH, Lo JO, Salati JA, et al. Quantitative assessment of placental perfusion by contrast-enhanced ultrasound in macaques and human subjects [J]. Am J Obstet Gynecol, 2016, 214(3): 369.e1-e8.
34
Krix M, Jenne JW. Ultrasound contrast agents. Pharmaceutical drug safety and bioeffects [J]. Radiology, 2007, 47(9): 800-807.
35
Barnett SB, Duck F, Ziskin M. Recommendations on the safe use of ultrasound contrast agents [J]. Ultrasound Med Biol, 2007, 33(2): 173-174.
36
陈佩文,陈欣林,赵胜, 等. 声诺维超声造影观察晚孕孕鼠胎盘超微结构改变的初步研究[J/CD]. 中华医学超声杂志(电子版), 2009, 6(01):19-24.
37
张婷,刘志跃,杨敬英, 等. 不同超声辐照联合超声造影剂对人孕早期绒毛组织的损伤作用 [J]. 中国医学影像学杂志, 2012, 20(6): 437-440, 444.
38
周雅琪,周争,王家东. 人绒毛膜促性腺激素对甲状腺乳头状癌的细胞增殖及周期的影响 [J]. 肿瘤防治研究, 2014, 41(7): 734-736.
39
Vannucchi G, Perrino M, Rossi S, et al. Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy [J]. Eur J Endocrinol, 2010, 162(1): 145-151.
40
全紫薇,金华. 妊娠期甲状腺肿瘤的诊断与治疗进展 [J]. 中国临床医生杂志, 2017, 45(10): 16-18.
41
Rakhlin L, Fish S. Pregnancy as a risk factor for thyroid cancer progression [J]. Curr Opin Endocrinol Diabetes Obes, 2018, 25(5): 326-329.
42
Chen AC, Livhits MJ, Du L, et al. Recent pregnancy is not associated with high risk pathological features of well differentiated thyroid cancer [J]. Thyroid, 2017, 28(1): 68-71.
43
沈莺,李梅芳,李连喜. 美国甲状腺协会2011年妊娠期及产后甲状腺疾病诊治指南解读 [J]. 世界临床药物, 2011, 32(10): 634-639.
44
Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum [J]. Thyroid, 2011, 21(10): 1081-1125.
45
Fussey JM, Khan H, Ahsan F, et al. Thyroid-stimulating hormone suppression therapy for differentiated thyroid cancer: The role for a combined T3/T4 approach [J]. Head Neck, 2017, 39(12): 2567-2572.
46
Landers K, Richard K. Traversing barriers - How thyroid hormones pass placental, blood-brain and blood-cerebrospinal fluid barriers [J]. Mol Cell Endocrinol, 2017, 458: 22-28.
47
Koren R, Wiener Y, Or K, et al. Thyroid Disease in Pregnancy: A Clinical Survey among Endocrinologists, Gynecologists, and Obstetricians in Israel [J]. Isr Med Assoc J, 2018, 20(3): 167-171.
48
周玮,黄婷. 妊娠期甲状腺疾病监测与处理 [J]. 中国实用妇科与产科杂志, 2017, 33(3): 263-267.
49
Hyer S, Pratt B, Newbold K, et al. Outcome of Pregnancy After Exposure to Radioiodine In Utero [J]. Endocr Pract, 2011, 17: 1-10. [Epub ahead of print].
50
Neta G, Hatch M, Kitahara CM, et al. In utero exposure to iodine-131 from Chernobyl fallout and anthropometric characteristics in adolescence [J]. Radiation Research, 2014, 181(3): 293-301.
51
Imran SA, Rajaraman M. Management of differentiated thyroid cancer in pregnancy [J]. J Thyroid Res, 2011: 549609.
No related articles found!
阅读次数
全文


摘要